Efficacy of Oxycodone for Dyspnea in End-stage Heart Failure with Renal Insufficiency

A 67-year-old man with dilated cardiomyopathy and renal insufficiency was admitted to our hospital with dyspnea secondary to end-stage heart failure. We introduced oxycodone for medically refractory dyspnea instead of morphine because of the patient's renal insufficiency. After the administrati...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Masayuki, Maeba, Hirofumi, Senoo, Takeshi, Iwasaka, Junji, Ohkita, Aki, Kita, Haruna, Uchitani, Kazuki, Hirota, Yasuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799057/
https://www.ncbi.nlm.nih.gov/pubmed/29033442
http://dx.doi.org/10.2169/internalmedicine.9216-17
Descripción
Sumario:A 67-year-old man with dilated cardiomyopathy and renal insufficiency was admitted to our hospital with dyspnea secondary to end-stage heart failure. We introduced oxycodone for medically refractory dyspnea instead of morphine because of the patient's renal insufficiency. After the administration of oxycodone, his dyspnea was alleviated without any adverse opioid effects, such as respiratory depression. After treating his heart failure, he was able to leave the intensive care unit. Oxycodone may therefore be a reliable agent for the treatment of dyspnea in patients with end-stage heart failure and renal insufficiency.

Ejemplares similares